Patents by Inventor Kirsten Sandvig

Kirsten Sandvig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210113482
    Abstract: The invention is related to the field nanoparticles and medical use. In particular, it relates to cabazitaxel (CBZ) as active ingredient encapsulated into poly (alkyl cyanoacrylate) nanoparticles for use in treatment of cancer.
    Type: Application
    Filed: March 27, 2019
    Publication date: April 22, 2021
    Inventors: Yrr Mørch, Ruth Schmid, Einar Sulheim, Per Stenstad, Heidi Johnsen, Kirsten Sandvig, Gunhild Mælandsmo, Tore Skotland, Kjersti Flatmark
  • Publication number: 20180031562
    Abstract: The present invention relates to methods for screening for prostate cancer in a subject. In particular, the present invention provides a method of for screening for prostate cancer in a subject, said method comprising determining the level of one or more of certain polypeptides in a urinary exosome-containing sample that has been obtained from a subject. Such methods can be used to for diagnosing prostate cancer, for the prognosis of prostate cancer, for monitoring the progression of prostate cancer in a subject, for determining the clinical severity of prostate cancer, for predicting the response of a subject to therapy, or for determining the efficacy of a therapeutic regime being used to treat prostate cancer.
    Type: Application
    Filed: January 14, 2016
    Publication date: February 1, 2018
    Inventors: Alicia LLORENTE, Tore SKOTLAND, Kirsten SANDVIG, Anders ØVERBYE
  • Publication number: 20150226745
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to lipids as diagnostic markers for prostate cancer.
    Type: Application
    Filed: February 28, 2013
    Publication date: August 13, 2015
    Inventors: Tore Skotland, Alicia Llorente, Kirsten Sandvig
  • Publication number: 20140296096
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to polypeptides found in extracellular microvesicles as diagnostic and screening markers, and clinical targets for cancer (e.g., prostate cancer).
    Type: Application
    Filed: March 27, 2014
    Publication date: October 2, 2014
    Applicant: Oslo universitetssykehus HF
    Inventors: Alicia Llorente, Tore Skotland, Kirsten Sandvig
  • Patent number: 5876989
    Abstract: A method for releasing molecules into the cytosol of cells without killing the majority of the cells by allowing the molecules to be taken up in endosomes, lysosomes or other cell compartments and use light activation of photosensitizing compounds to rupture the membranes of the endosomes, lysosomes or other cell compartments, is described.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: March 2, 1999
    Assignee: Photocure AS
    Inventors: Kristian Berg, Kirsten Sandvig, Johan Moan